Data From Controversial Landmark Stroke Therapy Trial Made Publicly Available, And Critics Comment
In December 1995, National Institute for Neurological Disorders (NINDS)rt-PA Stroke Trial was published, examining the effects of the clot-busting drug recombinant tissue plasminogen activator (rt-PA)in patients who had experienced acute stroke.
More: continued here
Filed under: Stroke on May 22nd, 2008